New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 12, 2014
16:31 EDTHAEHaemonetics sees margin headwinds from lower pricing, announces supply pact
Haemonetics announced that it has entered into a multi-year agreement to supply the HemeXcel Purchasing Alliance with certain whole blood collection components on an exclusive basis during calendar years 2014-2016. The announcement was made in conjunction with the 32nd Annual J.P. Morgan Health Care Conference in San Francisco. Haemonetics indicated that this incremental business volume will not have a material impact on fiscal 2014 revenue or earnings. Considered together with a smaller recent U.S. tender that was not awarded to Haemonetics, this incremental volume will represent approximately five net points of U.S. whole blood disposables share gain in fiscal 2015 and beyond. Another major U.S. whole blood tender remains in process and is expected to be awarded early in calendar 2014. Haemonetics continues to work closely with this customer and is excited to have the opportunity to show its full range of capabilities. Brian Concannon, Haemonetics' President and CEO said, "The North American whole blood market is in a period of rapid change in which significantly reduced demand for blood products is driving collector consolidation and aggressive competitive pricing for whole blood consumables. While we are optimistic about what these trends mean for the introduction of our differentiated whole blood offering, we expect margin headwinds from lower pricing will more than offset any benefit related to this share gain in fiscal 2015. As we progress through the fiscal years beyond 2015, benefits of product value engineering and other internal initiatives are expected to offset these margin headwinds."
News For HAE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 23, 2015
10:00 EDTHAEOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Aixtron (AIXG) downgraded to Neutral from Overweight at JPMorgan... Cavium (CAVM) downgraded on checks at JMP Securities... Chico's (CHS) downgraded to Underperform from Peer Perform at Wolfe Research... Chipotle (CMG) downgraded on new E coli infections at Sterne Agee CRT... Constant Contact (CTCT) downgraded to Sell from Hold at Stifel... Fairchild (FCS) downgraded to Neutral from Positive at Susquehanna... Haemonetics (HAE) downgraded to Underperform from Market Perform at Raymond James... Jumei (JMEI) downgraded to Underperform from Buy at CLSA... Phillips 66 (PSX) downgraded to Sell from Neutral at Goldman... Power Integrations (POWI) downgraded to Neutral from Buy at Sidoti... Tata Motors (TTM) downgraded to Sell from Neutral at Goldman... Textura (TXTR) downgraded to Neutral from Outperform at Credit Suisse... TriVascular (TRIV) downgraded to Neutral from Buy at BTIG... Viacom (VIAB) downgraded to Hold from Buy at Deutsche Bank.
08:55 EDTHAEHaemonetics downgraded to Underperform on high expectations at Raymond James
As previously reported, Raymond James downgraded Haemonetics to Underperform from Market Perform. Analyst Lawrence Keusch downgraded shares due to worsening business headwinds not reflected in FY17 Street estimates and an uncertain growth outlook given the potential reset in growth outlook when a new CEO is selected.
07:19 EDTHAEHaemonetics downgraded to Underperform from Market Perform at Raymond James
Subscribe for More Information
November 16, 2015
09:21 EDTHAEHaemonetics management to meet with Jefferies
Meeting to be held in New York on November 16 hosted by Jefferies.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use